- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01959529
A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular Events (DEVOTE)
July 10, 2019 updated by: Novo Nordisk A/S
This trial is conducted globally.
The aim of this trial is to compare cardiovascular safety of insulin degludec versus insulin glargine in subjects with type 2 diabetes at high risk of cardiovascular events.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
7637
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Algiers, Algeria, 16000
- Novo Nordisk Investigational Site
-
Constantine, Algeria, 25000
- Novo Nordisk Investigational Site
-
Oran, Algeria, 31000
- Novo Nordisk Investigational Site
-
Sidi Bel Abbes, Algeria, 22000
- Novo Nordisk Investigational Site
-
-
-
-
-
Caba, Argentina, C1440AAD
- Novo Nordisk Investigational Site
-
Cordoba, Argentina, 5000
- Novo Nordisk Investigational Site
-
Mar del Plata, Argentina, B7600FZN
- Novo Nordisk Investigational Site
-
Rosario, Argentina, S2000CUD
- Novo Nordisk Investigational Site
-
Zarate, Argentina, B2800DGH
- Novo Nordisk Investigational Site
-
-
-
-
-
Fortaleza, Brazil, 60430-350
- Novo Nordisk Investigational Site
-
Porto Alegre, Brazil, 90035-170
- Novo Nordisk Investigational Site
-
-
Ceara
-
Fortaleza, Ceara, Brazil, 60115-282
- Novo Nordisk Investigational Site
-
-
Distrito Federal
-
Brasília, Distrito Federal, Brazil, 71625-009
- Novo Nordisk Investigational Site
-
-
Goias
-
Aparecida de Goiania, Goias, Brazil, 74935-530
- Novo Nordisk Investigational Site
-
-
Para
-
Belém, Para, Brazil, 66073-000
- Novo Nordisk Investigational Site
-
-
Sao Paulo
-
Mogi das Cruzes, Sao Paulo, Brazil, 08780-090
- Novo Nordisk Investigational Site
-
São Paulo, Sao Paulo, Brazil, 05403-000
- Novo Nordisk Investigational Site
-
São Paulo, Sao Paulo, Brazil, 01223-001
- Novo Nordisk Investigational Site
-
São Paulo, Sao Paulo, Brazil, 01228-000
- Novo Nordisk Investigational Site
-
São Paulo, Sao Paulo, Brazil, 01228-200
- Novo Nordisk Investigational Site
-
-
-
-
Alberta
-
Edmonton, Alberta, Canada, T5J 3N4
- Novo Nordisk Investigational Site
-
-
Manitoba
-
Winnipeg, Manitoba, Canada, R3E 3P4
- Novo Nordisk Investigational Site
-
-
Ontario
-
Chatham, Ontario, Canada, N7L 1C1
- Novo Nordisk Investigational Site
-
Ottawa, Ontario, Canada, K1K 4L2
- Novo Nordisk Investigational Site
-
Sarnia, Ontario, Canada, N7T 4X3
- Novo Nordisk Investigational Site
-
-
Quebec
-
Laval, Quebec, Canada, H7T 2P5
- Novo Nordisk Investigational Site
-
-
-
-
-
Bjelovar, Croatia, 43000
- Novo Nordisk Investigational Site
-
Osijek, Croatia, 31 000
- Novo Nordisk Investigational Site
-
Slavonski Brod, Croatia, 35 000
- Novo Nordisk Investigational Site
-
Zagreb, Croatia, 10 000
- Novo Nordisk Investigational Site
-
Zagreb, Croatia, 10000
- Novo Nordisk Investigational Site
-
-
-
-
-
Athens, Greece, GR-17562
- Novo Nordisk Investigational Site
-
Athens, Greece, GR-11527
- Novo Nordisk Investigational Site
-
Athens, Greece, GR-115 27
- Novo Nordisk Investigational Site
-
Athens, Greece, GR-10552
- Novo Nordisk Investigational Site
-
Thessaloniki, Greece, GR-57001
- Novo Nordisk Investigational Site
-
Thessaloniki, Greece, GR-54642
- Novo Nordisk Investigational Site
-
-
-
-
-
Ludhiana, India, 141001
- Novo Nordisk Investigational Site
-
New Delhi, India, 110001
- Novo Nordisk Investigational Site
-
-
Andhra Pradesh
-
Hyderabad, Andhra Pradesh, India, 500034
- Novo Nordisk Investigational Site
-
Hyderbad, Andhra Pradesh, India, 500 012
- Novo Nordisk Investigational Site
-
-
Gujarat
-
Ahmedabad, Gujarat, India, 380006
- Novo Nordisk Investigational Site
-
Ahmedabad, Gujarat, India, 380052
- Novo Nordisk Investigational Site
-
Ahmedabad, Gujarat, India, 380007
- Novo Nordisk Investigational Site
-
Ahmedabad, Gujarat, India, 380016
- Novo Nordisk Investigational Site
-
-
Haryana
-
Gurgaon, Haryana, India, 122001
- Novo Nordisk Investigational Site
-
-
Karnataka
-
Bangalore, Karnataka, India, 560034
- Novo Nordisk Investigational Site
-
Bangalore, Karnataka, India, 560 017
- Novo Nordisk Investigational Site
-
-
Kerala
-
Kozhikode, Kerala, India, 673017
- Novo Nordisk Investigational Site
-
-
Madhya Pradesh
-
Indore, Madhya Pradesh, India, 452010
- Novo Nordisk Investigational Site
-
-
Maharashtra
-
Goa, Maharashtra, India, 403 202
- Novo Nordisk Investigational Site
-
Mumbai, Maharashtra, India, 400008
- Novo Nordisk Investigational Site
-
Mumbai, Maharashtra, India, 400012
- Novo Nordisk Investigational Site
-
Mumbai, Maharashtra, India, 400022
- Novo Nordisk Investigational Site
-
Mumbai, Maharashtra, India, 400010
- Novo Nordisk Investigational Site
-
Mumbai, Maharashtra, India, 400007
- Novo Nordisk Investigational Site
-
Pune, Maharashtra, India, 411001
- Novo Nordisk Investigational Site
-
Pune, Maharashtra, India, 411040
- Novo Nordisk Investigational Site
-
-
New Delhi
-
New Dehli, New Delhi, India, 110029
- Novo Nordisk Investigational Site
-
-
Orissa
-
Bhubaneswar, Orissa, India, 751005
- Novo Nordisk Investigational Site
-
-
Punjab
-
Mohali, Punjab, India, 160062
- Novo Nordisk Investigational Site
-
-
Tamil Nadu
-
Chennai, Tamil Nadu, India, 600086
- Novo Nordisk Investigational Site
-
Chennai, Tamil Nadu, India, 600031
- Novo Nordisk Investigational Site
-
Coimbatore, Tamil Nadu, India, 641018
- Novo Nordisk Investigational Site
-
-
Uttar Pradesh
-
Lucknow, Uttar Pradesh, India, 226014
- Novo Nordisk Investigational Site
-
-
West Bengal
-
Kolkata, West Bengal, India, 700020
- Novo Nordisk Investigational Site
-
Kolkata, West Bengal, India, 700054
- Novo Nordisk Investigational Site
-
-
-
-
-
Bari, Italy, 70124
- Novo Nordisk Investigational Site
-
Bergamo, Italy, 24127
- Novo Nordisk Investigational Site
-
Catanzaro, Italy, 88100
- Novo Nordisk Investigational Site
-
Chieti, Italy, 66100
- Novo Nordisk Investigational Site
-
Milano, Italy, 20122
- Novo Nordisk Investigational Site
-
Milano, Italy, 20162
- Novo Nordisk Investigational Site
-
Milano (MI), Italy, 20132
- Novo Nordisk Investigational Site
-
Olbia, Italy, 07026
- Novo Nordisk Investigational Site
-
Padova, Italy, 35143
- Novo Nordisk Investigational Site
-
Palermo, Italy, 90127
- Novo Nordisk Investigational Site
-
Ravenna, Italy, 48121
- Novo Nordisk Investigational Site
-
Roma, Italy, 00161
- Novo Nordisk Investigational Site
-
Roma, Italy, 00133
- Novo Nordisk Investigational Site
-
Sesto San Giovanni (MI), Italy, 20099
- Novo Nordisk Investigational Site
-
-
-
-
-
Chuo-ku, Tokyo, Japan, 103-0002
- Novo Nordisk Investigational Site
-
Kanagawa, Japan, 235-0045
- Novo Nordisk Investigational Site
-
Kumamoto, Japan, 862-0976
- Novo Nordisk Investigational Site
-
Miyazaki, Japan, 880-0034
- Novo Nordisk Investigational Site
-
Nagano, Japan, 390-8621
- Novo Nordisk Investigational Site
-
Ota-ku, Japan, 144 0035
- Novo Nordisk Investigational Site
-
Ota-ku, Tokyo, Japan, 1430015
- Novo Nordisk Investigational Site
-
Shinjuku-ku, Tokyo, Japan, 162-8655
- Novo Nordisk Investigational Site
-
-
-
-
-
Goyang, Korea, Republic of, 10380
- Novo Nordisk Investigational Site
-
Seoul, Korea, Republic of, 02841
- Novo Nordisk Investigational Site
-
Seoul, Korea, Republic of, 03080
- Novo Nordisk Investigational Site
-
Suwon-si, Gyeonggi-do, Korea, Republic of, 16247
- Novo Nordisk Investigational Site
-
-
-
-
-
Alor Setar, Malaysia, 05460
- Novo Nordisk Investigational Site
-
Kota Samarahan, Malaysia, 94300
- Novo Nordisk Investigational Site
-
Kuala Lumpur, Malaysia, 59100
- Novo Nordisk Investigational Site
-
Kuantan, Malaysia, 25100
- Novo Nordisk Investigational Site
-
Melaka, Malaysia, 75400
- Novo Nordisk Investigational Site
-
Serdang, Malaysia, 43000
- Novo Nordisk Investigational Site
-
Seremban, Malaysia, 70300
- Novo Nordisk Investigational Site
-
-
-
-
-
Aguascalientes, Mexico, 20230
- Novo Nordisk Investigational Site
-
Chihuahua, Mexico, 31200
- Novo Nordisk Investigational Site
-
San Luis Potosi, Mexico, 78200
- Novo Nordisk Investigational Site
-
-
Jalisco
-
Guadalajara, Jalisco, Mexico, 44600
- Novo Nordisk Investigational Site
-
Guadalajara, Jalisco, Mexico, 44130
- Novo Nordisk Investigational Site
-
Guadalajara, Jalisco, Mexico, 44650
- Novo Nordisk Investigational Site
-
Guadalajara, Jalisco, Mexico, 44670
- Novo Nordisk Investigational Site
-
Guadalajara, Jalisco, Mexico, 44150
- Novo Nordisk Investigational Site
-
-
Morelos
-
Cuernavaca, Morelos, Mexico, 62250
- Novo Nordisk Investigational Site
-
-
México, D.F.
-
Distrito Federal, México, D.F., Mexico, 14080
- Novo Nordisk Investigational Site
-
-
-
-
-
Bytom, Poland, 41-902
- Novo Nordisk Investigational Site
-
Gdansk, Poland, 80-546
- Novo Nordisk Investigational Site
-
Krakow, Poland, 31-455
- Novo Nordisk Investigational Site
-
Oswiecim, Poland, 32-600
- Novo Nordisk Investigational Site
-
Poznan, Poland, 60-589
- Novo Nordisk Investigational Site
-
Szczecin, Poland, 70-506
- Novo Nordisk Investigational Site
-
Warszawa, Poland, 02-507
- Novo Nordisk Investigational Site
-
Zamosc, Poland, 22-400
- Novo Nordisk Investigational Site
-
-
-
-
Alba
-
Alba Iulia, Alba, Romania, 510053
- Novo Nordisk Investigational Site
-
-
Maramures
-
Baia Mare, Maramures, Romania, 430222
- Novo Nordisk Investigational Site
-
-
Mures
-
Targu Mures, Mures, Romania, 540142
- Novo Nordisk Investigational Site
-
-
Prahova
-
Ploiesti, Prahova, Romania, 100163
- Novo Nordisk Investigational Site
-
-
-
-
-
Ekaterinburg, Russian Federation, 620102
- Novo Nordisk Investigational Site
-
Kemerovo, Russian Federation, 650002
- Novo Nordisk Investigational Site
-
Kirov, Russian Federation, 610014
- Novo Nordisk Investigational Site
-
Krasnodar, Russian Federation, 350012
- Novo Nordisk Investigational Site
-
Krasnodar, Russian Federation, 350086
- Novo Nordisk Investigational Site
-
Moscow, Russian Federation, 123423
- Novo Nordisk Investigational Site
-
Moscow, Russian Federation, 111539
- Novo Nordisk Investigational Site
-
Nizhny Novgorod, Russian Federation, 603018
- Novo Nordisk Investigational Site
-
Rostov-on-Don, Russian Federation, 344068
- Novo Nordisk Investigational Site
-
Saint-Petersburg, Russian Federation, 194356
- Novo Nordisk Investigational Site
-
Saint-Petersburg, Russian Federation, 195213
- Novo Nordisk Investigational Site
-
Saint-Petersburg, Russian Federation, 191119
- Novo Nordisk Investigational Site
-
Saratov, Russian Federation, 410053
- Novo Nordisk Investigational Site
-
Saratov, Russian Federation, 410031
- Novo Nordisk Investigational Site
-
St. Petersburg, Russian Federation, 194354
- Novo Nordisk Investigational Site
-
St. Petersburg, Russian Federation, 196084
- Novo Nordisk Investigational Site
-
Syktyvkar, Russian Federation, 167981
- Novo Nordisk Investigational Site
-
Tumen, Russian Federation, 625023
- Novo Nordisk Investigational Site
-
Tver, Russian Federation, 170036
- Novo Nordisk Investigational Site
-
Ulianovsk, Russian Federation, 432063
- Novo Nordisk Investigational Site
-
Volgograd, Russian Federation, 400131
- Novo Nordisk Investigational Site
-
Yaroslavl, Russian Federation, 150010
- Novo Nordisk Investigational Site
-
-
-
-
Eastern Cape
-
Port Elizabeth, Eastern Cape, South Africa, 6045
- Novo Nordisk Investigational Site
-
Port Elizabeth, Eastern Cape, South Africa, 6014
- Novo Nordisk Investigational Site
-
-
Gauteng
-
Johannesburg, Gauteng, South Africa, 2193
- Novo Nordisk Investigational Site
-
Johannesburg, Gauteng, South Africa, 1818
- Novo Nordisk Investigational Site
-
Johannesburg, Gauteng, South Africa, 2198
- Novo Nordisk Investigational Site
-
Pretoria, Gauteng, South Africa, 0001
- Novo Nordisk Investigational Site
-
-
KwaZulu-Natal
-
Durban, KwaZulu-Natal, South Africa, 4001
- Novo Nordisk Investigational Site
-
Durban, KwaZulu-Natal, South Africa, 4092
- Novo Nordisk Investigational Site
-
Umkomaas, KwaZulu-Natal, South Africa, 4170
- Novo Nordisk Investigational Site
-
-
Mpumalanga
-
Middleburg, Mpumalanga, South Africa, 1055
- Novo Nordisk Investigational Site
-
-
North West
-
Brits, North West, South Africa, 0250
- Novo Nordisk Investigational Site
-
-
Western Cape
-
Cape Town, Western Cape, South Africa, 7130
- Novo Nordisk Investigational Site
-
Cape Town, Western Cape, South Africa, 7500
- Novo Nordisk Investigational Site
-
Cape Town, Western Cape, South Africa, 7700
- Novo Nordisk Investigational Site
-
Cape Town, Western Cape, South Africa, 7460
- Novo Nordisk Investigational Site
-
-
-
-
-
Granada, Spain, 18012
- Novo Nordisk Investigational Site
-
Granada, Spain, 18003
- Novo Nordisk Investigational Site
-
Madrid, Spain, 28046
- Novo Nordisk Investigational Site
-
Málaga, Spain, 29006
- Novo Nordisk Investigational Site
-
Sevilla, Spain, 41009
- Novo Nordisk Investigational Site
-
Valencia, Spain, 46014
- Novo Nordisk Investigational Site
-
Valencia, Spain, 46015
- Novo Nordisk Investigational Site
-
-
-
-
-
Bangkok, Thailand, 10400
- Novo Nordisk Investigational Site
-
Bangkok, Thailand, 10330
- Novo Nordisk Investigational Site
-
Bangkoknoi, Bangkok, Thailand, 10700
- Novo Nordisk Investigational Site
-
Chiang Mai, Thailand, 50200
- Novo Nordisk Investigational Site
-
Nakhon Ratchasima, Thailand, 30000
- Novo Nordisk Investigational Site
-
-
-
-
-
Bristol, United Kingdom, BS10 5NB
- Novo Nordisk Investigational Site
-
Dundee, United Kingdom, DD1 9SY
- Novo Nordisk Investigational Site
-
Edinburgh, United Kingdom, EH4 2XU
- Novo Nordisk Investigational Site
-
Guildford, United Kingdom, GU2 7XX
- Novo Nordisk Investigational Site
-
Norwich, United Kingdom, NR4 7TJ
- Novo Nordisk Investigational Site
-
Nuneaton, United Kingdom, CV10 7DJ
- Novo Nordisk Investigational Site
-
Stevenage, United Kingdom, SG1 4AB
- Novo Nordisk Investigational Site
-
Wolverhampton, United Kingdom, WV10 0QP
- Novo Nordisk Investigational Site
-
-
-
-
Alabama
-
Birmingham, Alabama, United States, 35294
- Novo Nordisk Investigational Site
-
Birmingham, Alabama, United States, 35216
- Novo Nordisk Investigational Site
-
Montgomery, Alabama, United States, 36106
- Novo Nordisk Investigational Site
-
Montgomery, Alabama, United States, 36109
- Novo Nordisk Investigational Site
-
-
Arizona
-
Gilbert, Arizona, United States, 85295
- Novo Nordisk Investigational Site
-
Glendale, Arizona, United States, 85308
- Novo Nordisk Investigational Site
-
Litchfield Park, Arizona, United States, 85340
- Novo Nordisk Investigational Site
-
Phoenix, Arizona, United States, 85050
- Novo Nordisk Investigational Site
-
Tucson, Arizona, United States, 85714
- Novo Nordisk Investigational Site
-
Tucson, Arizona, United States, 85704
- Novo Nordisk Investigational Site
-
Tucson, Arizona, United States, 85723
- Novo Nordisk Investigational Site
-
-
Arkansas
-
Little Rock, Arkansas, United States, 72205
- Novo Nordisk Investigational Site
-
Little Rock, Arkansas, United States, 72205-5446
- Novo Nordisk Investigational Site
-
Searcy, Arkansas, United States, 72143
- Novo Nordisk Investigational Site
-
-
California
-
Chula Vista, California, United States, 91910
- Novo Nordisk Investigational Site
-
Concord, California, United States, 94520
- Novo Nordisk Investigational Site
-
Downey, California, United States, 90242
- Novo Nordisk Investigational Site
-
Duarte, California, United States, 91010
- Novo Nordisk Investigational Site
-
Encino, California, United States, 91436
- Novo Nordisk Investigational Site
-
Fresno, California, United States, 93720
- Novo Nordisk Investigational Site
-
Greenbrae, California, United States, 94904
- Novo Nordisk Investigational Site
-
Huntington Beach, California, United States, 92648
- Novo Nordisk Investigational Site
-
Inglewood, California, United States, 90301
- Novo Nordisk Investigational Site
-
La Jolla, California, United States, 92037
- Novo Nordisk Investigational Site
-
La Mesa, California, United States, 91942
- Novo Nordisk Investigational Site
-
Lancaster, California, United States, 93534
- Novo Nordisk Investigational Site
-
Long Beach, California, United States, 90822
- Novo Nordisk Investigational Site
-
Los Alamitos, California, United States, 90720
- Novo Nordisk Investigational Site
-
Mission Hills, California, United States, 91345
- Novo Nordisk Investigational Site
-
Montclair, California, United States, 91763
- Novo Nordisk Investigational Site
-
Monterey, California, United States, 93940
- Novo Nordisk Investigational Site
-
North Hollywood, California, United States, 91606
- Novo Nordisk Investigational Site
-
Palm Springs, California, United States, 92262
- Novo Nordisk Investigational Site
-
Poway, California, United States, 92064
- Novo Nordisk Investigational Site
-
San Diego, California, United States, 92111
- Novo Nordisk Investigational Site
-
San Diego, California, United States, 92120
- Novo Nordisk Investigational Site
-
San Ramon, California, United States, 94583
- Novo Nordisk Investigational Site
-
Santa Ana, California, United States, 92704
- Novo Nordisk Investigational Site
-
Sherman Oaks, California, United States, 91403
- Novo Nordisk Investigational Site
-
Thousand Oaks, California, United States, 91360
- Novo Nordisk Investigational Site
-
Tustin, California, United States, 92780
- Novo Nordisk Investigational Site
-
Ventura, California, United States, 93003
- Novo Nordisk Investigational Site
-
Vista, California, United States, 92083
- Novo Nordisk Investigational Site
-
Westminster, California, United States, 92683
- Novo Nordisk Investigational Site
-
-
Colorado
-
Colorado Springs, Colorado, United States, 80909
- Novo Nordisk Investigational Site
-
Denver, Colorado, United States, 80220
- Novo Nordisk Investigational Site
-
Denver, Colorado, United States, 80246
- Novo Nordisk Investigational Site
-
Golden, Colorado, United States, 80401
- Novo Nordisk Investigational Site
-
-
Connecticut
-
Danbury, Connecticut, United States, 06810
- Novo Nordisk Investigational Site
-
Norwalk, Connecticut, United States, 06851
- Novo Nordisk Investigational Site
-
Waterbury, Connecticut, United States, 06708
- Novo Nordisk Investigational Site
-
-
Florida
-
Boca Raton, Florida, United States, 33433
- Novo Nordisk Investigational Site
-
Boynton Beach, Florida, United States, 33472
- Novo Nordisk Investigational Site
-
Bradenton, Florida, United States, 34201
- Novo Nordisk Investigational Site
-
Brandon, Florida, United States, 33511
- Novo Nordisk Investigational Site
-
Clearwater, Florida, United States, 33756
- Novo Nordisk Investigational Site
-
Cooper City, Florida, United States, 33024
- Novo Nordisk Investigational Site
-
Fleming Island, Florida, United States, 32003
- Novo Nordisk Investigational Site
-
Fort Lauderdale, Florida, United States, 33316
- Novo Nordisk Investigational Site
-
Gainesville, Florida, United States, 32610
- Novo Nordisk Investigational Site
-
Green Cove Springs, Florida, United States, 32043
- Novo Nordisk Investigational Site
-
Hialeah, Florida, United States, 33012
- Novo Nordisk Investigational Site
-
Jacksonville, Florida, United States, 32216
- Novo Nordisk Investigational Site
-
Jacksonville, Florida, United States, 32207
- Novo Nordisk Investigational Site
-
Miami, Florida, United States, 33135
- Novo Nordisk Investigational Site
-
Miami, Florida, United States, 33136
- Novo Nordisk Investigational Site
-
Miami, Florida, United States, 33183
- Novo Nordisk Investigational Site
-
Miami, Florida, United States, 33155
- Novo Nordisk Investigational Site
-
Miami, Florida, United States, 33165
- Novo Nordisk Investigational Site
-
Naples, Florida, United States, 34119
- Novo Nordisk Investigational Site
-
New Port Richey, Florida, United States, 34652
- Novo Nordisk Investigational Site
-
Orlando, Florida, United States, 32806
- Novo Nordisk Investigational Site
-
Panama City, Florida, United States, 32401
- Novo Nordisk Investigational Site
-
Ponte Vedra, Florida, United States, 32081
- Novo Nordisk Investigational Site
-
Port Charlotte, Florida, United States, 33952
- Novo Nordisk Investigational Site
-
Port Orange, Florida, United States, 32127
- Novo Nordisk Investigational Site
-
South Miami, Florida, United States, 33143
- Novo Nordisk Investigational Site
-
Tampa, Florida, United States, 33624
- Novo Nordisk Investigational Site
-
Tampa, Florida, United States, 33619
- Novo Nordisk Investigational Site
-
-
Georgia
-
Atlanta, Georgia, United States, 30339
- Novo Nordisk Investigational Site
-
Decatur, Georgia, United States, 30033
- Novo Nordisk Investigational Site
-
Dunwoody, Georgia, United States, 30338
- Novo Nordisk Investigational Site
-
Lawrenceville, Georgia, United States, 30046
- Novo Nordisk Investigational Site
-
Roswell, Georgia, United States, 30076
- Novo Nordisk Investigational Site
-
Savannah, Georgia, United States, 31406
- Novo Nordisk Investigational Site
-
-
Hawaii
-
Honolulu, Hawaii, United States, 96814
- Novo Nordisk Investigational Site
-
-
Idaho
-
Idaho Falls, Idaho, United States, 83404-7596
- Novo Nordisk Investigational Site
-
-
Illinois
-
Addison, Illinois, United States, 60101
- Novo Nordisk Investigational Site
-
Champaign, Illinois, United States, 61821
- Novo Nordisk Investigational Site
-
Chicago, Illinois, United States, 60607
- Novo Nordisk Investigational Site
-
Chicago, Illinois, United States, 60616
- Novo Nordisk Investigational Site
-
Crystal Lake, Illinois, United States, 60012
- Novo Nordisk Investigational Site
-
Gurnee, Illinois, United States, 60031
- Novo Nordisk Investigational Site
-
Hines, Illinois, United States, 60141
- Novo Nordisk Investigational Site
-
Springfield, Illinois, United States, 62711
- Novo Nordisk Investigational Site
-
Springfield, Illinois, United States, 62702
- Novo Nordisk Investigational Site
-
-
Indiana
-
Brownsburg, Indiana, United States, 46112
- Novo Nordisk Investigational Site
-
Evansville, Indiana, United States, 47714
- Novo Nordisk Investigational Site
-
Franklin, Indiana, United States, 46131
- Novo Nordisk Investigational Site
-
Greenfield, Indiana, United States, 46140
- Novo Nordisk Investigational Site
-
Indianapolis, Indiana, United States, 46254
- Novo Nordisk Investigational Site
-
Michigan City, Indiana, United States, 46360
- Novo Nordisk Investigational Site
-
Muncie, Indiana, United States, 47304
- Novo Nordisk Investigational Site
-
-
Iowa
-
Council Bluffs, Iowa, United States, 51501
- Novo Nordisk Investigational Site
-
-
Kansas
-
Wichita, Kansas, United States, 67205
- Novo Nordisk Investigational Site
-
-
Kentucky
-
Lexington, Kentucky, United States, 40503
- Novo Nordisk Investigational Site
-
Lexington, Kentucky, United States, 40502
- Novo Nordisk Investigational Site
-
Louisville, Kentucky, United States, 40213
- Novo Nordisk Investigational Site
-
Louisville, Kentucky, United States, 40206
- Novo Nordisk Investigational Site
-
Madisonville, Kentucky, United States, 42431
- Novo Nordisk Investigational Site
-
-
Louisiana
-
Monroe, Louisiana, United States, 71203
- Novo Nordisk Investigational Site
-
New Orleans, Louisiana, United States, 70119
- Novo Nordisk Investigational Site
-
Shreveport, Louisiana, United States, 71103
- Novo Nordisk Investigational Site
-
Slidell, Louisiana, United States, 70461-4231
- Novo Nordisk Investigational Site
-
-
Maine
-
Bangor, Maine, United States, 04401
- Novo Nordisk Investigational Site
-
-
Maryland
-
Hyattsville, Maryland, United States, 20782
- Novo Nordisk Investigational Site
-
Rockville, Maryland, United States, 20852
- Novo Nordisk Investigational Site
-
-
Massachusetts
-
Watertown, Massachusetts, United States, 02472
- Novo Nordisk Investigational Site
-
Worcester, Massachusetts, United States, 01655
- Novo Nordisk Investigational Site
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48106
- Novo Nordisk Investigational Site
-
Ann Arbor, Michigan, United States, 48105
- Novo Nordisk Investigational Site
-
Buckley, Michigan, United States, 49620
- Novo Nordisk Investigational Site
-
Detroit, Michigan, United States, 48201
- Novo Nordisk Investigational Site
-
Detroit, Michigan, United States, 48202
- Novo Nordisk Investigational Site
-
Kalamazoo, Michigan, United States, 49009
- Novo Nordisk Investigational Site
-
Livonia, Michigan, United States, 48152
- Novo Nordisk Investigational Site
-
Troy, Michigan, United States, 48098
- Novo Nordisk Investigational Site
-
-
Mississippi
-
Olive Branch, Mississippi, United States, 38654
- Novo Nordisk Investigational Site
-
-
Missouri
-
Hazelwood, Missouri, United States, 63042
- Novo Nordisk Investigational Site
-
Jefferson City, Missouri, United States, 65109
- Novo Nordisk Investigational Site
-
Kansas City, Missouri, United States, 64111
- Novo Nordisk Investigational Site
-
-
Montana
-
Billings, Montana, United States, 59101
- Novo Nordisk Investigational Site
-
Kalispell, Montana, United States, 59901
- Novo Nordisk Investigational Site
-
-
Nebraska
-
Elkhorn, Nebraska, United States, 68022
- Novo Nordisk Investigational Site
-
Fremont, Nebraska, United States, 68025
- Novo Nordisk Investigational Site
-
Omaha, Nebraska, United States, 68114
- Novo Nordisk Investigational Site
-
Omaha, Nebraska, United States, 68105
- Novo Nordisk Investigational Site
-
Omaha, Nebraska, United States, 68124
- Novo Nordisk Investigational Site
-
Omaha, Nebraska, United States, 68144
- Novo Nordisk Investigational Site
-
Omaha, Nebraska, United States, 68198-4120
- Novo Nordisk Investigational Site
-
-
Nevada
-
Las Vegas, Nevada, United States, 89148
- Novo Nordisk Investigational Site
-
Las Vegas, Nevada, United States, 89128
- Novo Nordisk Investigational Site
-
Las Vegas, Nevada, United States, 89120
- Novo Nordisk Investigational Site
-
-
New Hampshire
-
Nashua, New Hampshire, United States, 03063
- Novo Nordisk Investigational Site
-
-
New Jersey
-
East Brunswick, New Jersey, United States, 08816
- Novo Nordisk Investigational Site
-
Hoboken, New Jersey, United States, 07030
- Novo Nordisk Investigational Site
-
-
New York
-
Albany, New York, United States, 12206
- Novo Nordisk Investigational Site
-
Lake Success, New York, United States, 11042
- Novo Nordisk Investigational Site
-
Mineola, New York, United States, 11501
- Novo Nordisk Investigational Site
-
New Windsor, New York, United States, 12553
- Novo Nordisk Investigational Site
-
New York, New York, United States, 10029
- Novo Nordisk Investigational Site
-
North Massapequa, New York, United States, 11758-1802
- Novo Nordisk Investigational Site
-
Northport, New York, United States, 11768
- Novo Nordisk Investigational Site
-
Rochester, New York, United States, 14607
- Novo Nordisk Investigational Site
-
West Seneca, New York, United States, 14224
- Novo Nordisk Investigational Site
-
Westfield, New York, United States, 14787
- Novo Nordisk Investigational Site
-
-
North Carolina
-
Asheville, North Carolina, United States, 28803
- Novo Nordisk Investigational Site
-
Asheville, North Carolina, United States, 28801
- Novo Nordisk Investigational Site
-
Burlington, North Carolina, United States, 27215
- Novo Nordisk Investigational Site
-
Cary, North Carolina, United States, 27518
- Novo Nordisk Investigational Site
-
Chapel Hill, North Carolina, United States, 27517
- Novo Nordisk Investigational Site
-
Charlotte, North Carolina, United States, 28209
- Novo Nordisk Investigational Site
-
Greenville, North Carolina, United States, 27834
- Novo Nordisk Investigational Site
-
Lexington, North Carolina, United States, 27292
- Novo Nordisk Investigational Site
-
Morehead City, North Carolina, United States, 28557
- Novo Nordisk Investigational Site
-
New Bern, North Carolina, United States, 28562
- Novo Nordisk Investigational Site
-
Statesville, North Carolina, United States, 28625
- Novo Nordisk Investigational Site
-
Whiteville, North Carolina, United States, 28472
- Novo Nordisk Investigational Site
-
Wilmington, North Carolina, United States, 28401
- Novo Nordisk Investigational Site
-
Winston-Salem, North Carolina, United States, 27103
- Novo Nordisk Investigational Site
-
-
North Dakota
-
Fargo, North Dakota, United States, 58104
- Novo Nordisk Investigational Site
-
-
Ohio
-
Cincinnati, Ohio, United States, 45236
- Novo Nordisk Investigational Site
-
Cleveland, Ohio, United States, 44195
- Novo Nordisk Investigational Site
-
Cleveland, Ohio, United States, 44106-1702
- Novo Nordisk Investigational Site
-
Cleveland, Ohio, United States, 44121
- Novo Nordisk Investigational Site
-
Columbus, Ohio, United States, 43235
- Novo Nordisk Investigational Site
-
Delaware, Ohio, United States, 43015
- Novo Nordisk Investigational Site
-
Franklin, Ohio, United States, 45005
- Novo Nordisk Investigational Site
-
Maumee, Ohio, United States, 43537
- Novo Nordisk Investigational Site
-
Mentor, Ohio, United States, 44060
- Novo Nordisk Investigational Site
-
Perrysburg, Ohio, United States, 43551
- Novo Nordisk Investigational Site
-
-
Oklahoma
-
Norman, Oklahoma, United States, 73069
- Novo Nordisk Investigational Site
-
Oklahoma City, Oklahoma, United States, 73104
- Novo Nordisk Investigational Site
-
-
Oregon
-
Portland, Oregon, United States, 97239-3098
- Novo Nordisk Investigational Site
-
-
Pennsylvania
-
Altoona, Pennsylvania, United States, 16602
- Novo Nordisk Investigational Site
-
Beaver, Pennsylvania, United States, 15009
- Novo Nordisk Investigational Site
-
Danville, Pennsylvania, United States, 17822
- Novo Nordisk Investigational Site
-
Hermitage, Pennsylvania, United States, 16148
- Novo Nordisk Investigational Site
-
Philadelphia, Pennsylvania, United States, 19107
- Novo Nordisk Investigational Site
-
Philadelphia, Pennsylvania, United States, 19114
- Novo Nordisk Investigational Site
-
Pittsburgh, Pennsylvania, United States, 15243
- Novo Nordisk Investigational Site
-
Pittsburgh, Pennsylvania, United States, 15212
- Novo Nordisk Investigational Site
-
Smithfield, Pennsylvania, United States, 15478
- Novo Nordisk Investigational Site
-
Uniontown, Pennsylvania, United States, 15401
- Novo Nordisk Investigational Site
-
Upper Darby, Pennsylvania, United States, 19082
- Novo Nordisk Investigational Site
-
Wilkes-Barre, Pennsylvania, United States, 18702
- Novo Nordisk Investigational Site
-
-
South Carolina
-
Anderson, South Carolina, United States, 29621
- Novo Nordisk Investigational Site
-
Greer, South Carolina, United States, 29651
- Novo Nordisk Investigational Site
-
Moncks Corner, South Carolina, United States, 29461
- Novo Nordisk Investigational Site
-
Murrells Inlet, South Carolina, United States, 29576
- Novo Nordisk Investigational Site
-
Myrtle Beach, South Carolina, United States, 29572
- Novo Nordisk Investigational Site
-
Orangeburg, South Carolina, United States, 29118
- Novo Nordisk Investigational Site
-
Spartanburg, South Carolina, United States, 29303
- Novo Nordisk Investigational Site
-
-
Tennessee
-
Chattanooga, Tennessee, United States, 37404
- Novo Nordisk Investigational Site
-
Chattanooga, Tennessee, United States, 37411
- Novo Nordisk Investigational Site
-
Chattanooga, Tennessee, United States, 37404-1192
- Novo Nordisk Investigational Site
-
Kingsport, Tennessee, United States, 37660
- Novo Nordisk Investigational Site
-
Knoxville, Tennessee, United States, 37938
- Novo Nordisk Investigational Site
-
Memphis, Tennessee, United States, 38119
- Novo Nordisk Investigational Site
-
Memphis, Tennessee, United States, 38163
- Novo Nordisk Investigational Site
-
Nashville, Tennessee, United States, 37212
- Novo Nordisk Investigational Site
-
Nashville, Tennessee, United States, 37203
- Novo Nordisk Investigational Site
-
Nashville, Tennessee, United States, 37208
- Novo Nordisk Investigational Site
-
Tullahoma, Tennessee, United States, 37388
- Novo Nordisk Investigational Site
-
-
Texas
-
Arlington, Texas, United States, 76012
- Novo Nordisk Investigational Site
-
Austin, Texas, United States, 78731
- Novo Nordisk Investigational Site
-
Austin, Texas, United States, 78749
- Novo Nordisk Investigational Site
-
Austin, Texas, United States, 78705
- Novo Nordisk Investigational Site
-
Carrollton, Texas, United States, 75010
- Novo Nordisk Investigational Site
-
Carrollton, Texas, United States, 75007
- Novo Nordisk Investigational Site
-
Corpus Christi, Texas, United States, 78404
- Novo Nordisk Investigational Site
-
Dallas, Texas, United States, 75230
- Novo Nordisk Investigational Site
-
Dallas, Texas, United States, 75390-9302
- Novo Nordisk Investigational Site
-
Dallas, Texas, United States, 75231
- Novo Nordisk Investigational Site
-
Dallas, Texas, United States, 75246
- Novo Nordisk Investigational Site
-
Fort Worth, Texas, United States, 76117
- Novo Nordisk Investigational Site
-
Fort Worth, Texas, United States, 76132
- Novo Nordisk Investigational Site
-
Houston, Texas, United States, 77024
- Novo Nordisk Investigational Site
-
Houston, Texas, United States, 77061
- Novo Nordisk Investigational Site
-
Houston, Texas, United States, 77008
- Novo Nordisk Investigational Site
-
Houston, Texas, United States, 77070
- Novo Nordisk Investigational Site
-
Houston, Texas, United States, 77099
- Novo Nordisk Investigational Site
-
Houston, Texas, United States, 77060
- Novo Nordisk Investigational Site
-
Houston, Texas, United States, 77029
- Novo Nordisk Investigational Site
-
Houston, Texas, United States, 77093
- Novo Nordisk Investigational Site
-
Humble, Texas, United States, 77338
- Novo Nordisk Investigational Site
-
Hurst, Texas, United States, 76054
- Novo Nordisk Investigational Site
-
Irving, Texas, United States, 75039
- Novo Nordisk Investigational Site
-
Lewisville, Texas, United States, 75067
- Novo Nordisk Investigational Site
-
Longview, Texas, United States, 75605
- Novo Nordisk Investigational Site
-
Lubbock, Texas, United States, 79423
- Novo Nordisk Investigational Site
-
Midland, Texas, United States, 79707
- Novo Nordisk Investigational Site
-
Odessa, Texas, United States, 79761
- Novo Nordisk Investigational Site
-
Pearland, Texas, United States, 77584
- Novo Nordisk Investigational Site
-
Richardson, Texas, United States, 75080
- Novo Nordisk Investigational Site
-
Round Rock, Texas, United States, 78681
- Novo Nordisk Investigational Site
-
San Antonio, Texas, United States, 78229
- Novo Nordisk Investigational Site
-
San Antonio, Texas, United States, 78215
- Novo Nordisk Investigational Site
-
San Antonio, Texas, United States, 78228-6205
- Novo Nordisk Investigational Site
-
San Antonio, Texas, United States, 78258
- Novo Nordisk Investigational Site
-
Splendora, Texas, United States, 77372
- Novo Nordisk Investigational Site
-
Sugar Land, Texas, United States, 77478
- Novo Nordisk Investigational Site
-
Sugar Land, Texas, United States, 77479
- Novo Nordisk Investigational Site
-
Waco, Texas, United States, 76710
- Novo Nordisk Investigational Site
-
-
Utah
-
Salt Lake City, Utah, United States, 84102
- Novo Nordisk Investigational Site
-
Salt Lake City, Utah, United States, 84132
- Novo Nordisk Investigational Site
-
-
Vermont
-
Bennington, Vermont, United States, 05201
- Novo Nordisk Investigational Site
-
South Burlington, Vermont, United States, 05403
- Novo Nordisk Investigational Site
-
-
Virginia
-
Midlothian, Virginia, United States, 23114
- Novo Nordisk Investigational Site
-
Norfolk, Virginia, United States, 23510
- Novo Nordisk Investigational Site
-
Richmond, Virginia, United States, 23249
- Novo Nordisk Investigational Site
-
Winchester, Virginia, United States, 22601-3834
- Novo Nordisk Investigational Site
-
-
Washington
-
Richland, Washington, United States, 99352
- Novo Nordisk Investigational Site
-
Spokane, Washington, United States, 99201
- Novo Nordisk Investigational Site
-
-
Wisconsin
-
Kenosha, Wisconsin, United States, 53144
- Novo Nordisk Investigational Site
-
Milwaukee, Wisconsin, United States, 53209
- Novo Nordisk Investigational Site
-
Milwaukee, Wisconsin, United States, 53295
- Novo Nordisk Investigational Site
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria: - Type 2 diabetes - Age above or equal to 50 years with predefined previous cardiovascular disease(s) or renal disease or age above or equal to 60 years with predefined cardiovascular risk factors - HbA1c (glycosylated haemoglobin) above or equal to 7.0% or HbA1c below 7.0% and current insulin treatment corresponding to above or equal to 20 U of basal insulin per day - One or more oral or injectable antidiabetic agent(s) Exclusion Criteria: - An acute coronary or cerebrovascular event in the previous 60 days - Planned coronary, carotid or peripheral artery revascularisation - Chronic heart failure NYHA (New York Heart Association) class IV - Current or past (within the last 5 years) malignant neoplasms (except basal cell and squamous cell skin carcinoma)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Insulin degludec (IDeg)
All subjects will continue their current antidiabetic therapy except for the basal insulin component (if any) that will be replaced by the investigational product.
|
Injected once daily subcutaneously (s.c., under the skin)
|
Active Comparator: Insulin glargine (IGlar)
All subjects will continue their current antidiabetic therapy except for the basal insulin component (if any) that will be replaced by the investigational product.
|
Injected once daily subcutaneously (s.c., under the skin)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time From Randomisation to First Occurrence of a Major Adverse Cardiovascular Event (MACE): Cardiovascular Death, Non-fatal Myocardial Infarction, or Non-fatal Stroke
Time Frame: From randomisation to individual end of trial date (maximum patient year observation: 2.75 years)
|
Time from randomisation to first occurrence of an event adjudication committee (EAC)-confirmed 3-component major adverse cardiovascular event (MACE): cardiovascular death, non-fatal myocardial infarction, or nonfatal stroke.
Events with EAC-confirmed onset date between randomisation and individual end of trial were included in the analyses.
The number of subjects experiencing first EAC-confirmed MACEs, date between randomisation to the end of trial, both days included were presented.
The trial was event driven and planned to last up to a maximum of 60.5 months.
The actual trial duration (time from first subject first visit to last subject last visit) was 35.6 months.
The maximum trial duration for a single subject was 33.1 months.
|
From randomisation to individual end of trial date (maximum patient year observation: 2.75 years)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of EAC-confirmed Severe Hypoglycaemic Episodes
Time Frame: From randomisation to individual end of trial (maximum patient year observation: 2.75 years)
|
Number of severe hypoglycaemic episodes from week 0 to the last assessment (up to 35.6 months).
The episode of severe hypoglycaemia is an episode requiring assistance of another person to actively administer carbohydrate, glucagon, or take other corrective actions.
The trial was event driven and planned to last up to a maximum of 60.5 months.
The actual trial duration (time from first subject first visit to last subject last visit) was 35.6 months.
The maximum trial duration for a single subject was 33.1 months.
|
From randomisation to individual end of trial (maximum patient year observation: 2.75 years)
|
Occurrence of at Least One EAC Confirmed Severe Hypoglycaemic Episode Within a Subject (Yes/no)
Time Frame: From randomisation to individual end of trial date (maximum patient year observation: 2.75 years)
|
Occurrence of at least one EAC-confirmed severe hypoglycaemic episode within a subject from week 0 to the last assessment (up to 35.6 months).
The episode of severe hypoglycaemia is an episode requiring assistance of another person to actively administer carbohydrate, glucagon, or take other corrective actions.
|
From randomisation to individual end of trial date (maximum patient year observation: 2.75 years)
|
Change in Glycosylated Haemoglobin (HbA1c)
Time Frame: Randomisation to 24 months
|
Mean change in HbA1c from week 0 to month 24.
|
Randomisation to 24 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Pollock RF, Heller S, Pieber TR, Woo V, Gundgaard J, Hallen N, Luckevich M, Tutkunkardas D, Zinman B; DEVOTE Study Group. Short-term cost-utility of degludec versus glargine U100 for patients with type 2 diabetes at high risk of hypoglycaemia and cardiovascular events: A Canadian setting (DEVOTE 9). Diabetes Obes Metab. 2019 Jul;21(7):1706-1714. doi: 10.1111/dom.13730. Epub 2019 Apr 14.
- Pollock RF, Valentine WJ, Marso SP, Andersen A, Gundgaard J, Hallen N, Tutkunkardas D, Magnuson EA, Buse JB; DEVOTE study group. Long-term Cost-effectiveness of Insulin Degludec Versus Insulin Glargine U100 in the UK: Evidence from the Basal-bolus Subgroup of the DEVOTE Trial (DEVOTE 16). Appl Health Econ Health Policy. 2019 Oct;17(5):615-627. doi: 10.1007/s40258-019-00494-3.
- Marso SP, McGuire DK, Zinman B, Poulter NR, Emerson SS, Pieber TR, Pratley RE, Haahr PM, Lange M, Frandsen KB, Rabol R, Buse JB. Design of DEVOTE (Trial Comparing Cardiovascular Safety of Insulin Degludec vs Insulin Glargine in Patients With Type 2 Diabetes at High Risk of Cardiovascular Events) - DEVOTE 1. Am Heart J. 2016 Sep;179:175-83. doi: 10.1016/j.ahj.2016.06.004. Epub 2016 Jun 18.
- Marso SP, McGuire DK, Zinman B, Poulter NR, Emerson SS, Pieber TR, Pratley RE, Haahr PM, Lange M, Brown-Frandsen K, Moses A, Skibsted S, Kvist K, Buse JB; DEVOTE Study Group. Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes. N Engl J Med. 2017 Aug 24;377(8):723-732. doi: 10.1056/NEJMoa1615692. Epub 2017 Jun 12.
- Zinman B, Marso SP, Poulter NR, Emerson SS, Pieber TR, Pratley RE, Lange M, Brown-Frandsen K, Moses A, Ocampo Francisco AM, Barner Lekdorf J, Kvist K, Buse JB; DEVOTE Study Group. Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2). Diabetologia. 2018 Jan;61(1):48-57. doi: 10.1007/s00125-017-4423-z. Epub 2017 Sep 15.
- Pieber TR, Marso SP, McGuire DK, Zinman B, Poulter NR, Emerson SS, Pratley RE, Woo V, Heller S, Lange M, Brown-Frandsen K, Moses A, Barner Lekdorf J, Lehmann L, Kvist K, Buse JB; DEVOTE Study Group. DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality. Diabetologia. 2018 Jan;61(1):58-65. doi: 10.1007/s00125-017-4422-0. Epub 2017 Sep 15.
- Pollock RF, Valentine WJ, Marso SP, Gundgaard J, Hallen N, Hansen LL, Tutkunkardas D, Buse JB; DEVOTE Study Group. DEVOTE 5: Evaluating the Short-Term Cost-Utility of Insulin Degludec Versus Insulin Glargine U100 in Basal-Bolus Regimens for Type 2 Diabetes in the UK. Diabetes Ther. 2018 Jun;9(3):1217-1232. doi: 10.1007/s13300-018-0430-4. Epub 2018 Apr 30.
- Theilgaard H, Mollerup I, Helmark IC, Endahl L, Hoskin S, Hvelplund A, Amby LK, Moses AC. Developing, Planning and Conducting an Interim Analysis: Lessons From the DEVOTE Cardiovascular Outcomes Trial (Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Patients With Type 2 Diabetes at High Risk of Cardiovascular Events). Ther Innov Regul Sci. 2019 Mar;53(2):279-286. doi: 10.1177/2168479018776943. Epub 2018 May 24.
- Brown-Frandsen K, Emerson SS, McGuire DK, Pieber TR, Poulter NR, Pratley RE, Zinman B, Ranthe MF, Gron R, Lange M, Moses AC, Orsy P, Buse JB; DEVOTE Study Group. Lower rates of cardiovascular events and mortality associated with liraglutide use in patients treated with basal insulin: A DEVOTE subanalysis (DEVOTE 10). Diabetes Obes Metab. 2019 Jun;21(6):1437-1444. doi: 10.1111/dom.13677. Epub 2019 Apr 1.
- Pratley RE, Emerson SS, Franek E, Gilbert MP, Marso SP, McGuire DK, Pieber TR, Zinman B, Hansen CT, Hansen MV, Mark T, Moses AC, Buse JB; DEVOTE Study Group. Cardiovascular safety and lower severe hypoglycaemia of insulin degludec versus insulin glargine U100 in patients with type 2 diabetes aged 65 years or older: Results from DEVOTE (DEVOTE 7). Diabetes Obes Metab. 2019 Jul;21(7):1625-1633. doi: 10.1111/dom.13699. Epub 2019 Apr 15.
- Klein KR, Franek E, Marso S, Pieber TR, Pratley RE, Gowda A, Kvist K, Buse JB. Hemoglobin glycation index, calculated from a single fasting glucose value, as a prediction tool for severe hypoglycemia and major adverse cardiovascular events in DEVOTE. BMJ Open Diabetes Res Care. 2021 Nov;9(2):e002339. doi: 10.1136/bmjdrc-2021-002339.
- Amod A, Buse JB, McGuire DK, Pieber TR, Pop-Busui R, Pratley RE, Zinman B, Hansen MB, Jia T, Mark T, Poulter NR; DEVOTE Study Group. Risk factors for kidney disorders in patients with type 2 diabetes at high cardiovascular risk: An exploratory analysis (DEVOTE 12). Diab Vasc Dis Res. 2020 Nov-Dec;17(6):1479164120970933. doi: 10.1177/1479164120970933.
- Heller S, Lingvay I, Marso SP, Philis-Tsimikas A, Pieber TR, Poulter NR, Pratley RE, Hachmann-Nielsen E, Kvist K, Lange M, Moses AC, Andresen MT, Buse JB; DEVOTE Study Group. Risk of severe hypoglycaemia and its impact in type 2 diabetes in DEVOTE. Diabetes Obes Metab. 2020 Dec;22(12):2241-2247. doi: 10.1111/dom.14049. Epub 2020 Jul 9.
- Pratley RE, Husain M, Lingvay I, Pieber TR, Mark T, Saevereid HA, Moller DV, Zinman B; DEVOTE Study Group. Heart failure with insulin degludec versus glargine U100 in patients with type 2 diabetes at high risk of cardiovascular disease: DEVOTE 14. Cardiovasc Diabetol. 2019 Nov 15;18(1):156. doi: 10.1186/s12933-019-0960-8.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 29, 2013
Primary Completion (Actual)
October 16, 2016
Study Completion (Actual)
October 16, 2016
Study Registration Dates
First Submitted
October 8, 2013
First Submitted That Met QC Criteria
October 8, 2013
First Posted (Estimate)
October 10, 2013
Study Record Updates
Last Update Posted (Actual)
July 24, 2019
Last Update Submitted That Met QC Criteria
July 10, 2019
Last Verified
July 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EX1250-4080
- 2013-002371-17 (EudraCT Number)
- U1111-1141-7614 (Other Identifier: WHO)
- JapicCTI-142464 (Registry Identifier: JAPIC)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus, Type 2
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Mannkind CorporationTerminatedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
RWTH Aachen UniversityBoehringer IngelheimCompletedDiabetes Mellitus Type 2 (T2DM)Germany
-
Scripps Whittier Diabetes InstituteSan Diego State UniversityCompletedType 2 Diabetes Mellitus (T2DM)United States
-
University Hospital Inselspital, BerneCompletedType 2 Diabetes MellitusSwitzerland
-
India Diabetes Research Foundation & Dr. A. Ramachandran...CompletedTYpe 2 Diabetes MellitusIndia
-
Griffin HospitalCalifornia Walnut CommissionCompletedDIABETES MELLITUS TYPE 2United States
-
US Department of Veterans AffairsAmerican Diabetes AssociationCompletedType 2 Diabetes MellitusUnited States
-
Dexa Medica GroupCompletedType-2 Diabetes MellitusIndonesia
-
Diabetes Foundation, IndiaNational Diabetes Obesity and Cholesterol FoundationRecruitingType 2 Diabetes Mellitus With ComplicationIndia
Clinical Trials on insulin degludec
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Germany
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Austria
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, France, Austria, Norway, Algeria
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Germany
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Germany
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Germany
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Malaysia, Germany, Algeria, Turkey
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Mexico, Puerto Rico, Canada, Denmark, France, Austria, Taiwan, Czechia, Brazil, China, Argentina
-
Sunshine Lake Pharma Co., Ltd.Not yet recruiting